Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$686M |
| 2 |
Merck
MRK
|
+$536M |
| 3 |
GoDaddy
GDDY
|
+$330M |
| 4 |
CSX Corp
CSX
|
+$227M |
| 5 |
Aramark
ARMK
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$372M |
| 2 |
DexCom
DXCM
|
+$339M |
| 3 |
Broadcom
AVGO
|
+$321M |
| 4 |
Adobe
ADBE
|
+$280M |
| 5 |
Meta Platforms (Facebook)
META
|
+$273M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.38% |
| 2 | Healthcare | 16.14% |
| 3 | Financials | 13.58% |
| 4 | Industrials | 12.86% |
| 5 | Consumer Discretionary | 11.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VVC
1026
DELISTED
Vectren Corporation
VVC
| $5.03M | ﹤0.01% |
70,410
-4,400
| -6% | -$314K |
|
1027
Nuveen Preferred & Income Opportunities Fund
JPC
$2.89B
| $5.02M | ﹤0.01% |
541,469
| – | – |
|
1028
International Paper
IP
$22.5B
| $4.99M | ﹤0.01% |
107,244
-20,714
| -16% | -$1.03M |
|
1029
British American Tobacco
BTI
$131B
| $4.99M | ﹤0.01% |
106,893
+260
| +0.2% | +$13.2K |
|
1030
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.47B
| $4.98M | ﹤0.01% |
28,750
-5,000
| -15% | -$841K |
|
1031
Realty Income
O
$61.1B
| $4.95M | ﹤0.01% |
89,777
+8,493
| +10% | +$468K |
|
1032
TAL Education Group
TAL
$5.86B
| $4.94M | ﹤0.01% |
192,292
-389,100
| -67% | -$12.6M |
|
1033
Vanguard FTSE Emerging Markets ETF
VWO
$120B
| $4.84M | ﹤0.01% |
118,042
+48,629
| +70% | +$2.05M |
|
1034
Host Hotels & Resorts
HST
$17.1B
| $4.81M | ﹤0.01% |
227,991
+31,696
| +16% | +$670K |
|
1035
iShares MSCI South Korea ETF
EWY
$22.5B
| $4.79M | ﹤0.01% |
70,101
-15,500
| -18% | -$1.03M |
|
1036
APA Corp
APA
$12.3B
| $4.78M | ﹤0.01% |
100,256
-5,178
| -5% | -$233K |
|
1037
Bunge Global
BG
$22.8B
| $4.77M | ﹤0.01% |
69,403
+23,516
| +51% | +$1.55M |
|
1038
Cardinal Health
CAH
$53.7B
| $4.77M | ﹤0.01% |
88,319
+4,822
| +6% | +$247K |
|
1039
Toll Brothers
TOL
$14.1B
| $4.76M | ﹤0.01% |
144,105
-579,020
| -80% | -$21M |
|
1040
ManpowerGroup
MAN
$2.5B
| $4.75M | ﹤0.01% |
55,209
-444,956
| -89% | -$39.6M |
|
1041
Pembina Pipeline
PBA
$29B
| $4.67M | ﹤0.01% |
136,871
+8,267
| +6% | +$287K |
|
1042
Skyworks Solutions
SWKS
$9.54B
| $4.62M | ﹤0.01% |
50,936
+2,278
| +5% | +$213K |
|
1043
Boston Properties
BXP
$11B
| $4.59M | ﹤0.01% |
37,294
-213
| -0.6% | -$27.1K |
|
1044
Vanguard Financials ETF
VFH
$13.5B
| $4.59M | ﹤0.01% |
66,107
+1,633
| +3% | +$115K |
|
|
HDS
1045
DELISTED
HD Supply Holdings, Inc.
HDS
| $4.59M | ﹤0.01% |
107,173
+87,629
| +448% | +$3.84M |
|
1046
Vornado Realty Trust
VNO
$7.43B
| $4.54M | ﹤0.01% |
62,185
+14,136
| +29% | +$1.05M |
|
1047
Penumbra
PEN
$12.6B
| $4.51M | ﹤0.01% |
+30,100
| New | +$4.22M |
|
1048
Sonida Senior Living
SNDA
$2.03B
| $4.47M | ﹤0.01% |
31,618
-1,953
| -6% | -$265K |
|
1049
BCE
BCE
$19.8B
| $4.47M | ﹤0.01% |
110,457
+7,325
| +7% | +$302K |
|
|
SFE
1050
DELISTED
Safeguard Scientifics, Inc.
SFE
| $4.42M | ﹤0.01% |
474,347
+49,960
| +12% | +$543K |
|
Similar funds
Janus Henderson Group's Q3 2018 Portfolio in Review
As of Q3 2018, Janus Henderson Group held 1,505 positions worth $187B, up 6.7% from $175B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Janus Henderson Group's Q3 2018 filing shows 118 new, 660 increased, 620 reduced and 63 closed positions. Its largest new stake was Elanco Animal Health: 1,976,916 shares worth $69M. The largest sale was Biogen, an estimated $372M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2018 buy was Elanco Animal Health: 1,976,916 shares worth $69M.
- Janus Henderson Group added most to Apple in Q3 2018, an estimated $686M increase.
- Janus Henderson Group's biggest Q3 2018 reduction was Biogen, cutting an estimated $372M.
- Janus Henderson Group fully exited Financial Engines, Inc. in Q3 2018, selling an estimated $190M.
- Janus Henderson Group's ten largest holdings make up 16% of its $187B portfolio in Q3 2018.
- Janus Henderson Group opened 118 new positions and closed 63 in Q3 2018.
- Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $187B.
Based on Janus Henderson Group's 13F filing for Q3 2018, filed 9 Nov 2018.